tiprankstipranks
Trending News
More News >
Acotec Scientific Holdings Limited (HK:6669)
:6669

Acotec Scientific Holdings Limited (6669) Price & Analysis

Compare
0 Followers

6669 Stock Chart & Stats


Financials

6669 FAQ

What was Acotec Scientific Holdings Limited’s price range in the past 12 months?
Acotec Scientific Holdings Limited lowest stock price was HK$5.26 and its highest was HK$9.60 in the past 12 months.
    What is Acotec Scientific Holdings Limited’s market cap?
    Acotec Scientific Holdings Limited’s market cap is HK$2.70B.
      When is Acotec Scientific Holdings Limited’s upcoming earnings report date?
      Acotec Scientific Holdings Limited’s upcoming earnings report date is Aug 27, 2025 which is in 57 days.
        How were Acotec Scientific Holdings Limited’s earnings last quarter?
        Acotec Scientific Holdings Limited released its earnings results on Mar 24, 2025. The company reported HK$0.045 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.045.
          Is Acotec Scientific Holdings Limited overvalued?
          According to Wall Street analysts Acotec Scientific Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Acotec Scientific Holdings Limited pay dividends?
            Acotec Scientific Holdings Limited does not currently pay dividends.
            What is Acotec Scientific Holdings Limited’s EPS estimate?
            Acotec Scientific Holdings Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Acotec Scientific Holdings Limited have?
            Acotec Scientific Holdings Limited has 313,389,160 shares outstanding.
              What happened to Acotec Scientific Holdings Limited’s price movement after its last earnings report?
              Acotec Scientific Holdings Limited reported an EPS of HK$0.045 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.258%.
                Which hedge fund is a major shareholder of Acotec Scientific Holdings Limited?
                Currently, no hedge funds are holding shares in HK:6669

                Company Description

                Acotec Scientific Holdings Limited

                Acotec Scientific Holdings Limited, a medical device company, researches and develops percutaneous transluminal angioplasty and drug-coated balloon products for the treatment of vascular diseases in Mailand China, Europe, and internationally. It offers AcoArt Orchid & Dhalia to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease; under clinical studies in nephrology for arteriovenous fistula stenosis and in neurology for vertebral atherosclerotic stenosis indications/applications; and under clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company also provides AcoArt Tulip & Litos, which is under registration process in China and Europe, and under preclinical studies in the United States in vascular surgery for below-the-knee artery disease indications/applications; and in pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company was incorporated in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited is a subsidiary of CA Medtech Investment (Cayman) Limited.
                Similar Stocks
                Company
                Price & Change
                Follow
                Peijia Medical Ltd.
                MicroPort CardioFlow Medtech Corp.
                MicroTech Medical (Hangzhou) Co., Ltd. Class H
                Venus Medtech (Hangzhou), Inc. Class H
                Shanghai Heartcare Medical Technology Corp. Ltd. Class H
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis